Kazumasa Fukuda - Publications

Clinical significance of combining circulating tumor DNA and endoscopic response evaluation for esophageal squamous cell carcinoma.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: December 09, 2025

A SNP-based capture and clustering workflow to assess donor-derived cell-free DNA in transplantation.

Journal: PloS one

Published: August 08, 2025

Current status and clinical usefulness of genomic panel testing using PleSSision-160 in resectable esophageal squamous cell carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 28, 2025

PDGFRα-positive mesenchymal stem/stromal cells contribute to autonomous vascular formation through in-body tissue architecture.

Journal: PloS one

Published: June 25, 2025

Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 24, 2025

MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression.

Journal: Oncogene

Published: May 12, 2025

Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal Cancer.

Journal: Cancer medicine

Published: May 10, 2025

DCF-resistant ESCC redevelops drug sensitivity when combined with calcium channel blockers due to ER stress response.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: March 24, 2025

Impact of COVID-19 on hospital visit behaviour in cancer patients in Japan: a nationwide study.

Journal: BMJ open

Published: December 26, 2024

Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 21, 2024

MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.

Journal: NPJ breast cancer

Published: September 05, 2024

Risk factors for pneumonia after endoscopic laryngopharyngeal surgery in cases with prior esophageal cancer treatment.

Journal: Annals of gastroenterological surgery

Published: September 04, 2024